| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.9 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.9 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |